Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial infections

  • L. von Konow
  • P. Å. Köndell
  • C. E. Nord
  • A. Heimdahl


The efficacy of clindamycin and phenoxymethylpenicillin in the treatment of orofacial infections was compared in a randomised study in 60 patients: 30 patients received clindamycin 150 mg every 6 h for seven days, and 30 received phenoxymethylpenicillin 1 g every 12 h for seven days. Where indicated incision and drainage were carried out. All patients but one in each group responded satisfactorily to treatment. Although the clindamycin group had a shorter duration of pain, swelling and fever and more favourable laboratory findings, the differences between the groups were not statistically significant. Of the 60 microbiological specimens 23 yielded only anaerobic bacteria, 34 both anaerobic and aerobic bacteria, two aerobic bacteria only and one no growth. In the penicillin group one case of severe diarrhoea occurred, and six patients in the clindamycin group had moderate to severe gastrointestinal discomfort, including one case ofClostridium difficile associated diarrhoea. This difference was however not statistically significant. The results support the continued use of penicillin for treatment of orofacial infections, with clindamycin serving as an effective alternative.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Finegold SM, Baron EJ, Wexler HM: A clinical guide to anaerobic infections. Star Publishing, Belmont, CA, 1992.Google Scholar
  2. 2.
    Bartlett JG, O'Keefe P: The bacteriology of perimandibular space infections. Journal of Oral Surgery 1979, 37: 407–409.Google Scholar
  3. 3.
    von Konow L, Nord CE, Nordenram Å: Anaerobic bacteria in dentoalveolar infections. International Journal of Oral Surgery 1982, 10: 313–322.Google Scholar
  4. 4.
    Tabaqchali S: Anaerobic infections in the head and neck region. Scandinavian Journal of Infectious Diseases 1988, Supplement 57: 24–34.Google Scholar
  5. 5.
    Lewis MAO, MacFarlane TW, McGowan DA: A microbiological and clinical review of the acute dentoalveolar abscess. British Journal of Oral and Maxillofacial Surgery 1990, 28: 359–366.Google Scholar
  6. 6.
    Heimdahl A, von Konow L, Nord CE: Isolation of β-lactamase-producingBacteroides strains associated with clinical failures with penicillin treatment of orofacial infections. Archives of Oral Biology 1980, 25: 689–692.Google Scholar
  7. 7.
    Heimdahl A, von Konow L, Nord CE: Clinical significance of penicillin-resistant β-lactamase-producingBacteroides species in human orofacial infections. In: Ullman U (ed): Proceedings of the β-lactam symposium. Springer, Kiel, 1983, p. 49–56.Google Scholar
  8. 8.
    Bahn SL, Ciola B, Segal AG: Penicillin-resistantBacteroides melaninogenicus infection in the mandible. Journal of Oral Surgery 1981, 39: 221–223.Google Scholar
  9. 9.
    Lewis MAO, MacFarlane TW, McGowan DA: Antibiotic susceptibilities of bacteria isolated from acute dentoalveolar abscesses. Journal of Antimicrobial Chemotherapy 1989, 23: 69–77.Google Scholar
  10. 10.
    Heimdahl A, von Konow L, Nord CE: β-lactamase-producingBacteroides species in the oral cavity in the relation to penicillin therapy. Journal of Antimicrobial Chemotherapy 1981, 8: 225–229.Google Scholar
  11. 11.
    Aronsson B, Möllby R, Nord CE:Clostridium difficile and antibiotic associated diarrhoea in Sweden. Scandinavian Journal of Infectious Diseases 1982, Supplement 35: 53–58.Google Scholar
  12. 12.
    Nord CE, Kager L, Heimdahl A: Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. American Journal of Medicine 1984, 76: 99–106.Google Scholar
  13. 13.
    Bayliss R, Clarke C, Oakley CM, Sommerville W, Whitfield AGW, Young SEJ: The microbiology and pathogenesis of infective endocarditis. British Heart Journal 1983, 50: 513–519.Google Scholar
  14. 14.
    Heimdahl A, Mattson T, Dahllöf G, Lönnqvist B, Ringdén O: The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surgery, Oral Medicine, Oral Pathology 1989, 68: 711–716.Google Scholar
  15. 15.
    von Konow L, Nord CE: Ornidazale compared to phenoxymethylpenicillin in the treatment of orofacial infections. Journal of Antimicrobial Chemotherapy 1983, 11: 207–215.Google Scholar
  16. 16.
    Lennette EH, Balows A, Hausler WJ, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1985.Google Scholar
  17. 17.
    Ericsson HM, Sherris JC: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavica 1971, Supplement 217: 64–73.Google Scholar
  18. 18.
    Dornbusch K, Nord CE, Wadström T: Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates ofBacteroides fragilis. Scandinavian Journal of Infectious Diseases 1974, 6: 253–258.Google Scholar
  19. 19.
    Baker PJ, Evans RT, Slots J, Genco RJ: Antibiotic susceptibility of anaerobic bacteria from the human oral cavity. Journal of Dental Research 1985, 64: 1233–1244.Google Scholar
  20. 20.
    Edson RS, Rosenblatt JE, Lee DT, McVey EA: Recent experience with antimicrobial susceptibility of anaerobic bacteria. Mayo Clinic Proceedings 1982, 57: 737–741.Google Scholar
  21. 21.
    Gilmore WC, Jacobus NV, Gorbach SL, Doku HC, Tally FP: A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections. Journal of Oral and Maxillofacial Surgery 1988, 4: 1065–1070.Google Scholar
  22. 22.
    Whitcher BL, Beirne OR, Smith RA: Beta-lactamase-producingBacteroides melaninogenicus and osteomyelitis of the mandible. Journal of Oral Medicine 1983, 38: 17–20.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1992

Authors and Affiliations

  • L. von Konow
    • 1
  • P. Å. Köndell
    • 1
  • C. E. Nord
    • 2
    • 3
  • A. Heimdahl
    • 1
  1. 1.Department of Oral SurgeryHuddinge University Hospital, Karolinska InstituteHuddingeSweden
  2. 2.Department of MicrobiologyHuddinge University Hospital, Karolinska InstituteHuddingeSweden
  3. 3.National Bacteriological LaboratoryStockholmSweden

Personalised recommendations